As the UK government eased COVID-19 lockdown measures, citizens are enjoying the warm spring weather on the Bournemouth beach in the southwest of England on the 30th of last month (local time). In the England region of the UK, outdoor exercise and outdoor gatherings of up to six people have been allowed since the day before. <Photo by Yonhap News>

As the UK government eased COVID-19 lockdown measures, citizens are enjoying the warm spring weather on the Bournemouth beach in the southwest of England on the 30th of last month (local time). In the England region of the UK, outdoor exercise and outdoor gatherings of up to six people have been allowed since the day before.

View original image


The COVID-19 vaccine 'Moderna' has begun to be administered in the United Kingdom.


The COVID-19 vaccines available in the UK have increased to three, following Pfizer and AstraZeneca.


On the 7th (local time), BBC reported, "A 24-year-old woman caring for her grandmother in Wales was the first to receive the Moderna vaccine."


The UK has ordered 17 million doses of the Moderna vaccine.


The Moderna vaccine is also administered twice with a few weeks interval. It uses the same 'messenger ribonucleic acid' (mRNA) technology as Pfizer and is stored at minus 20 degrees Celsius. Its efficacy was reported to be 94.1%.


Although the UK has been aggressively rolling out vaccinations, the pace has slowed recently due to delays in AstraZeneca vaccine supplies from India and ongoing safety concerns related to blood clots.


On the 5th, the number of first-dose recipients was 40,744, a sharp decrease from 752,308 two weeks earlier, according to Sky News. This also reflects an increase in the proportion of second-dose vaccinations.



In the UK, 31.6 million adults, accounting for 60% of the adult population, have received their first dose. The number of people who have completed the second dose reaches 5.4 million.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing